维普中文期刊产品整合服务
180篇 您的检索式:作者名="Rejnmark"
    题名 作者 年代 出处 被引量
1Hip fracture risk in statin users-a population-based Danish case-control study 显示文摘REJNMARK L OLSEN ML JOHNSEN SP 2004Osteoporos lnt2004,15,:1
2Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk 显示文摘Vestergaard P Rejnmark L Mosekilde L 2005Diabetologia2005,48,7:1
3Reduced fracture risk in users of thiazide diuretics显示文摘Rejnmark L Vestergaard P Mosekilde L 2005Calcif Tissue Int2005,76,3:1
4Emerging anabolic treatments in osteoporosis显示文摘Mosekilde L Torring O Rejnmark L 2011Current Drug Safety2011,6,2:1
5Influence of hyperand hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk显示文摘Vestergaard P Rejnmark L Mosekilde L 2005Calcif Tissue Int2005,77,3:1
6Fracture risk perimenopausal women treated with beat -blockers显示文摘Rejnmark L Vestergaard P Kassem M 2004Calcif Tissue Int2004,75,5:1
7Increased mor- tality in patients with a hip fracture-effect of pre-morbid and postfracture complications 显示文摘Vestergaard P Rejnmark L Mosekilde L 2007Osteoporos Int2007,18,:1
8Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture 显示文摘Vestergaard P Rejnmark L Mosekilde L 2006Calcif Tissue Int2006,79,2:1
9Effect of simvastatin on bone turnover and BMD:a 1-year randomized controlled trial in postmenopausal osteopenic women显示文摘Rejnmark L Buus NH Vestewgaard P 2004J Bone Miner Res2004,19,5:1
10Mosekilde L Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark 显示文摘Vestergaard P Rejnmark L 2005Osteoporosis Int2005,16,:1
11Fracture rates and risk fac-tors for fractures in patients with spinal cord injury 显示文摘Vestergaard P Krogh K Rejnmark L 1998Spinal Cord1998,36,11:1
12Emerging anabolic treatments in osteoporosis 显示文摘Mosekilde L Tsrring O Rejnmark L 2011CurrDrug Safety2011,6,2:1
13Statin but not non- statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study显示文摘Rejnmark L Vestergaard P Mosekilde L 2006Calcif Tissue Int2006,79,1:1
14Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopansal women: results from a randomized controlled study with bumetanide显示文摘Rejnmark L Vestergaard P Heickendorff L 2006J Bone Miner Res2006,21,1:1
15Effect of hormone replacement the-rapy on cardiovascular events in recently postmenopausal women:randomised trial显示文摘Schierbeck LL Rejnmark L Tofieng CL 2012BMJ2012,345,2:1
16Cardiovascular drugs and bone显示文摘Rejnmark L 2008Curr Drug Saf2008,3,:1
17Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture显示文摘Vestergaard P Rejnmark L Mosekilde L 2006Calcif Tissue Int2006,79,2:1
18Statin but not non-statinlipid-lowering drugs decrease fracture risk:a nation-wide case-control study显示文摘Rejnmark L Vestergaard P Mosekilde L 2006Calcif Tissue Int2006,79,1:1
19Relative fracture risk in patients with diabetes mellitus,and the impact of insulin and oral antidiabetic medication on relative fracture risk显示文摘Vestergaard P Rejnmark L Mosekilde L 2005Diabetologia2005,48,7:1
20Intake of vitamin D and risk of breast cancer--a meta-analysis显示文摘Gissel T Rejnmark L Mosekilde L 2008J Steroid Biochem Mol Biol2008,111,35:1
返回顶部 每页显示:
共9页 首页 上一页 第1页 下一页 末页 /9 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费